Robert Pierce

2021 - Sensei Biotherapeutics

In 2021, Robert Pierce earned a total compensation of $2.3M as Former Chief R&D Officer at Sensei Biotherapeutics.

Compensation breakdown

Non-Equity Incentive Plan$167,700
Option Awards$1,620,922
Salary$410,000
Other$62,791
Total$2,261,413

Pierce received $1.6M in option awards, accounting for 72% of the total pay in 2021.

Pierce also received $167.7K in non-equity incentive plan, $410K in salary and $62.8K in other compensation.

Rankings

In 2021, Robert Pierce's compensation ranked 5,557th out of 12,415 executives tracked by ExecPay. In other words, Pierce earned more than 55.2% of executives.

ClassificationRankingPercentile
All
5,557
out of 12,415
55th
Division
Manufacturing
2,351
out of 5,505
57th
Major group
Chemicals And Allied Products
1,022
out of 2,375
57th
Industry group
Drugs
911
out of 2,096
57th
Industry
Pharmaceutical Preparations
656
out of 1,546
58th
Source: SEC filing on June 15, 2023.

Pierce's colleagues

We found two more compensation records of executives who worked with Robert Pierce at Sensei Biotherapeutics in 2021.

2021

John Celebi

Sensei Biotherapeutics

Chief Executive Officer

2021

Erin Colgan

Sensei Biotherapeutics

Chief Financial Officer

News

In-depth

You may also like